Skip to main navigation Skip to main content Skip to page footer

Colangite sclerosante primaria

Informazioni cliniche

La colangite sclerosante primaria (CSP) è una malattia cronica del fegato con distruzione progressiva dei dotti biliari. La CSP ha una prevalenza di circa 8-14 pazienti su 100.000 persone. Gli uomini sono più frequentemente colpiti dalla malattia rispetto alle donne (60-80%) e la malattia viene diagnosticata principalmente all'età di 30-60 anni. La CSP si manifesta più spesso in pazienti con malattie infiammatorie croniche dell'intestino (85-90% colite ulcerosa e 10-15% malattia di Crohn). La maggior parte dei pazienti con CSP presenta autoanticorpi contro i granulociti (pANCA) il cui principale antigene bersaglio è la lattoferrina legata al DNA.

Diagnostica

La colangiografia è il metodo più rilevante per ottenere una diagnosi affidabile. Sebbene nella CSP siano presenti numerosi autoanticorpi, non si tratta di una tipica malattia autoimmune. Tuttavia, può essere associata a fenomeni autoimmuni nell'infanzia e alla presenza di alti titoli di autoanticorpi (ANA, ANCA e ASMA). Nei casi sospetti di sindrome da sovrapposizione con epatite autoimmune o colangite biliare primaria (fino al 10% dei casi), i test anticorpali sierologici possono fornire ulteriori informazioni diagnostiche.

Methods
Technology Parameter Substrate Species Calibration Ig Class Format Order No.
EUROLINE EUROLINE Anti-MPO, -PR3 and -GBM (IgG)
myeloperoxidase
proteinase 3 (PR3)
glomerular basement membrane
EUROLINE IgG
IgG
16 x 01
64 x 01
DL 1200-1601-3 G
DL 1200-6401-3 G
ChLIA IDS ANCA/GBM Control Set 3 x 1.5 ml Control 1/2 human serum 2 concentrations
IS-AI17301
ChLIA IDS AMA (M2)
MIT3
antigenic coated magnetic particles MIT3 quantitative
50 x 01
IS-AI18011
ChLIA IDS Liver Control Set 3 x 1.5 ml Control 1/2 human serum 2 concentrations
IS-AI18301
IIFT antibodies against granulocyte cytoplasm,
cytoplasmic pattern (cANCA control, PR3 ab control)
IgG 05 x 02
CA 1200-0502
IIFT antibodies against granulocyte cytoplasm,
perinuclear pattern (pANCA control)
IgG 05 x 02
CA 1210-0502
IIFT antibodies against granulocyte cytoplasm, perinuclear pattern
(pANCA control, MPO ab control)
IgG 05 x 02
CA 1211-0502
IIFT cytoplasm of granulocytes (cANCA,
pANCA), nuclei of granulocytes (GS-ANA)
granulocytes,
ethanol-fixed
human IgG
IgG
IgG
IgG
10 x 05
10 x 10
180 x 10
20 x 05
10 x 05
10 x 10
20 x 05
FA 1200-1005
FA 1200-1010
FA 1200-18010
FA 1200-2005
FB 1200-1005
FB 1200-1010
FB 1200-2005
IIFT granulocytes
(cANCA, pANCA)
granulocytes,
formaldehyde-fixed
human IgG
IgG
10 x 05
10 x 10
10 x 05
10 x 10
FA 1201-1005
FA 1201-1010
FB 1201-1005
FB 1201-1010
IIFT Granulocyte Mosaic 13
cANCA, pANCA, GS-ANA
cell nuclei (ANA), cANCA, pANCA
cANCA, pANCA
3 BIOCHIPs per field:
granulocytes (EOH)
HEp-2+granulocytes (EOH)
granulocytes (HCHO)

human
human
human
IgG
IgG
IgG
IgG
IgG
IgG
10 x 05
10 x 10
10 x 50
120 x 10
20 x 05
20 x 10
10 x 05
10 x 10
10 x 50
20 x 05
20 x 10
FA 1201-1005-13
FA 1201-1010-13
FA 1201-1050-13
FA 1201-12010-13
FA 1201-2005-13
FA 1201-2010-13
FB 1201-1005-13
FB 1201-1010-13
FB 1201-1050-13
FB 1201-2005-13
FB 1201-2010-13
IIFT Granulocyte Mosaic 15
cANCA, pANCA, GS-ANA
cell nuclei (ANA), cANCA, pANCA
2 BIOCHIPs per field:
granulocytes (EOH)
HEp-2+granulocytes (EOH)

human
human
IgG
IgG
IgG
IgG
10 x 05
10 x 10
20 x 05
20 x 10
10 x 05
10 x 10
20 x 05
20 x 10
FA 1201-1005-15
FA 1201-1010-15
FA 1201-2005-15
FA 1201-2010-15
FB 1201-1005-15
FB 1201-1010-15
FB 1201-2005-15
FB 1201-2010-15
IIFT Granulocyte Mosaic 2
cANCA, pANCA, GS-ANA
cANCA, pANCA
2 BIOCHIPs per field:
granulocytes (EOH)
granulocytes (HCHO)

human
human
IgG
IgG
IgG
IgG
10 x 05
10 x 10
20 x 05
20 x 10
10 x 05
10 x 10
20 x 05
20 x 10
FA 1201-1005-2
FA 1201-1010-2
FA 1201-2005-2
FA 1201-2010-2
FB 1201-1005-2
FB 1201-1010-2
FB 1201-2005-2
FB 1201-2010-2
IIFT EUROPLUS Granulocyte Mosaic 22
cANCA, pANCA, GS-ANA
cANCA, pANCA
pANCA: myeloperoxidase (MPO)
cANCA: proteinase 3 (PR3)
4 BIOCHIPs per field:
granulocytes (EOH)
granulocytes (HCHO)
MPO BIOCHIPs
PR3 BIOCHIPs

human
human
IgG
IgG
IgG
10 x 05
10 x 10
20 x 05
10 x 05
10 x 10
FA 1201-1005-22
FA 1201-1010-22
FA 1201-2005-22
FB 1201-1005-22
FB 1201-1010-22
IIFT EUROPLUS Granulocyte Mosaic 25
cANCA, pANCA, GS-ANA
cell nuclei (ANA), cANCA, pANCA
cANCA, pANCA
glomerular basement membrane (GBM)
pANCA: myeloperoxidase (MPO)
cANCA: proteinase 3 (PR3)
6 BIOCHIPs per field:
granulocytes (EOH)
HEp-2+granulocytes (EOH)
granulocytes (HCHO)
GBM BIOCHIPs
MPO BIOCHIPs
PR3 BIOCHIPs

human
human
human
IgG
IgG
IgG
IgG
10 x 05
10 x 10
20 x 05
20 x 10
10 x 05
20 x 05
20 x 10
FA 1201-1005-25
FA 1201-1010-25
FA 1201-2005-25
FA 1201-2010-25
FB 1201-1005-25
FB 1201-2005-25
FB 1201-2010-25
IIFT EUROPLUS Granulocyte Mosaic 32
cANCA, pANCA, GS-ANA
cANCA, pANCA
cell nuclei (ANA), cANCA, pANCA
pANCA: myeloperoxidase (MPO)
cANCA: proteinase 3 (PR3)
5 BIOCHIPs per field:
granulocytes (EOH)
granulocytes (HCHO)
HEp-2+granulocytes (EOH)
MPO BIOCHIPs
PR3 BIOCHIPs

human
human
human
IgG
IgG
IgG
IgG
10 x 05
10 x 10
20 x 05
20 x 10
10 x 05
10 x 10
20 x 05
20 x 10
FA 1201-1005-32
FA 1201-1010-32
FA 1201-2005-32
FA 1201-2010-32
FB 1201-1005-32
FB 1201-1010-32
FB 1201-2005-32
FB 1201-2010-32
IIFT cytoplasm of granulocytes (cANCA,
pANCA), nuclei of granulocytes (GS-ANA)
EUROPattern
granulocytes,
ethanol-fixed
human IgG EB
IgG EB
IgG EB
IgG EB
IgG EB
10 x 05
10 x 10
120 x 10
20 x 05
20 x 10
FC 1200-1005
FC 1200-1010
FC 1200-12010
FC 1200-2005
FC 1200-2010
IIFT granulocytes
(cANCA, pANCA)
EUROPattern
granulocytes,
formaldehyde-fixed
human IgG EB
IgG EB
IgG EB
10 x 05
10 x 10
20 x 05
FC 1201-1005
FC 1201-1010
FC 1201-2005
IIFT Granulocyte Mosaic 13 EUROPattern
cANCA, pANCA, GS-ANA, EUROPattern
cell nuclei (ANA), cANCA, pANCA
cANCA, pANCA, EUROPattern
3 BIOCHIPs per field:
granulocytes (EOH)
HEp-2+granulocytes (EOH)
granulocytes (HCHO)

human
human
human
IgG EB
IgG EB
IgG EB
IgG EB
IgG EB
IgG EB
IgG EB
IgG EB
10 x 05
10 x 10
120 x 10
20 x 05
20 x 10
24 x 50
10 x 05
20 x 10
FC 1201-1005-13
FC 1201-1010-13
FC 1201-12010-13
FC 1201-2005-13
FC 1201-2010-13
FC 1201-2450-13
FW 1201-1005-13
FW 1201-2010-13
IIFT Granulocyte Mosaic 15 EUROPattern
cANCA, pANCA, GS-ANA, EUROPattern
cell nuclei (ANA), cANCA, pANCA
2 BIOCHIPs per field:
granulocytes (EOH)
HEp-2+granulocytes (EOH)

human
human
IgG EB
IgG EB
IgG EB
IgG EB
IgG EB
10 x 05
10 x 10
10 x 50
20 x 10
10 x 05
FC 1201-1005-15
FC 1201-1010-15
FC 1201-1050-15
FC 1201-2010-15
FW 1201-1005-15
IIFT Granulocyte Mosaic 2 EUROPattern
cANCA, pANCA, GS-ANA, EUROPattern
cANCA, pANCA, EUROPattern
2 BIOCHIPs per field:
granulocytes (EOH)
granulocytes (HCHO)

human
human
IgG EB
IgG EB
IgG EB
IgG EB
IgG EB
10 x 05
10 x 10
120 x 10
20 x 05
20 x 10
FC 1201-1005-2
FC 1201-1010-2
FC 1201-12010-2
FC 1201-2005-2
FC 1201-2010-2
IIFT EUROPLUS Granulocyte Mosaic 22
EUROPattern
cANCA, pANCA, GS-ANA, EUROPattern
cANCA, pANCA, EUROPattern
pANCA: myeloperoxidase (MPO), EUROPattern
cANCA: proteinase 3 (PR3), EUROPattern
4 BIOCHIPs per field:

granulocytes (EOH)
granulocytes (HCHO)
MPO BIOCHIPs
PR3 BIOCHIPs


human
human
IgG EB
IgG EB
IgG EB
10 x 05
10 x 10
20 x 10
FC 1201-1005-22
FC 1201-1010-22
FC 1201-2010-22
IIFT EUROPLUS Granulocyte Mosaic 25
EUROPattern
cANCA, pANCA, GS-ANA, EUROPattern
cell nuclei (ANA), cANCA, pANCA
cANCA, pANCA, EUROPattern
glom. basement membrane (GBM), EUROPattern
pANCA: myeloperoxidase (MPO), EUROPattern
cANCA: proteinase 3 (PR3), EUROPattern
6 BIOCHIPs per field:

granulocytes (EOH)
HEp-2+granulocytes (EOH)
granulocytes (HCHO)
GBM BIOCHIPs
MPO BIOCHIPs
PR3 BIOCHIPs


human
human
human
IgG EB
IgG EB
IgG EB
IgG EB
IgG EB
IgG EB
10 x 05
10 x 10
20 x 05
20 x 10
10 x 05
20 x 10
FC 1201-1005-25
FC 1201-1010-25
FC 1201-2005-25
FC 1201-2010-25
FW 1201-1005-25
FW 1201-2010-25
IIFT EUROPLUS Granulocyte Mosaic 32
EUROPattern
cANCA, pANCA, GS-ANA, EUROPattern
cANCA, pANCA, EUROPattern
cell nuclei (ANA), cANCA, pANCA
pANCA: myeloperoxidase (MPO), EUROPattern
cANCA: proteinase 3 (PR3), EUROPattern
5 BIOCHIPs per field:

granulocytes (EOH)
granulocytes (HCHO)
HEp-2+granulocytes (EOH)
MPO BIOCHIPs
PR3 BIOCHIPs


human
human
human
IgG EB
IgG EB
IgG EB
IgG EB
IgG EB
IgG EB
IgG EB
10 x 05
10 x 10
120 x 10
20 x 05
20 x 10
10 x 05
10 x 10
FC 1201-1005-32
FC 1201-1010-32
FC 1201-12010-32
FC 1201-2005-32
FC 1201-2010-32
FW 1201-1005-32
FW 1201-1010-32
ELISA ANCA-Profile ELISA (IgG)
(proteinase 3, MPO, elastase, cathepsin G, BPI, lactoferrin separately)
antigen-coated
microplate wells
native, human
neutrophil granulocytes
recombinant, human c-DNA
expressed in human cell line
semi-quantitative IgG 12 x 08
EA 1200-1208-1 G
ELISA Anti-PR3-hn-hr ELISA (IgG)
cANCA: proteinase 3
antigen-coated
microplate wells
hn: native, human
neutrophil granulocytes
hr: recombinant, human c-DNA
expressed in human cell line
2/20/200 RU/ml IgG 96 x 01
EA 1201-9601-2 G
ELISA Anti-MPO ELISA (IgG)
pANCA: myeloperoxidase
antigen-coated
microplate wells
native, human
neutrophil granulocytes
2/20/200 RU/ml IgG 96 x 01
EA 1211-9601 G
EUROLINE positive control serum: IgG, human, 100x concentrated
for DL 1200-X G
IgG 05 x 07
CL 1200-0507-2 G
EUROLINE EUROLINE Anti-MPO, -PR3 (IgG)
myeloperoxidase
proteinase 3
EUROLINE IgG
IgG
16 x 01
64 x 01
DL 1200-1601-2 G
DL 1200-6401-2 G
ChLIA IDS MPO antigenic coated magnetic particles MPO quantitative
50 x 01
IS-AI17011
ChLIA IDS PR3-II antigenic coated magnetic particles PR3 quantitative
50 x 01
IS-AI1702II1
ChLIA Anti-PR3 ChLIA (IgG) Antigen-coated magnetic particles quantitative IgG 100 x 1
LA 1201-10010 G
ChLIA Anti-Myeloperoxidase ChLIA (IgG) Antigen-coated magnetic particles quantitative IgG 100 x 1
LA 1211-10010 G
ChLIA Control set Anti-PR3 ChLIA (IgG) 2 x 0.4 ml control 1/2 IgG 02 x 02
LR 1201-20210 G
ChLIA Control set Anti-Myeloperoxidase ChLIA (IgG) 2 x 0.4 ml control 1/2 IgG 02 x 02
LR 1211-20210 G
* For research use only, not for in vitro diagnostic use in the sense of EU directive 98/79/EC.
1 Product manufactured by third party. Please contact your local Euroimmun representative for more information.